Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
03/2003
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1295866A1 4-membered ring compound and optical phase retardation plate using the same
03/26/2003EP1294823A1 Double-spiro organic compounds and electroluminescent devices
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
03/26/2003EP1294679A1 Beta-amino acid nitrile derivatives
03/26/2003EP1294677A1 Benzophenones and sulfones as inhibitors of glycine uptake
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003CN1406239A Process for the production of thienopyrimidine derivatives
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538144 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use
03/25/2003US6538038 A method of treating a warm-blooded animal having a vascular proliferative disorder, comprising administering, to the animal, an amount of a prodrug of a tubulin binding agent, other than combretastatin A4 disodium phosphate to achieve
03/25/2003US6537995 Heterocyclic carboxamides
03/25/2003US6537527 Skin lightening compositions
03/21/2003WO2002022555A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2002091993A3 Estrogen receptor modulators
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003WO2002040431B1 Compounds having fungicidal activity and processes to make and use same
03/20/2003US20030055291 Oxidation of alcohols in the presence of osmium compounds as catalysts in water or a solvent mixture
03/20/2003US20030055287 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
03/20/2003US20030055269 Reacting a p-phenylacetic acid derivative in an acid halogenating reaction, reacting further with a malonic ester, magnesium alkoxide, sulfur and a nitriloacetic ester in the presence of a primary amine
03/20/2003US20030055263 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
03/20/2003US20030055261 Compounds with growth hormone releasing properties
03/20/2003US20030055247 Thiazolyl(pyridyl)ethyne compounds
03/20/2003US20030055110 Retinoid compounds suited for antibacterial applications
03/20/2003US20030055100 Cytotoxic compounds
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055086 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
03/20/2003US20030055038 For therapy of central nervous system and other disorders
03/20/2003US20030055025 For therapy of bacterial infections and neoplasms,
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/19/2003EP1293506A1 New 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazine derivatives, process for their preparation and pharmaceutical compositions containing the same
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP0984914B1 Substituted 2-(3-alkenyl-benzoyl)-cyclohexane-1,3-diones
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/19/2003EP0799228B1 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as anti-parasitic agents
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
03/18/2003US6534545 Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
03/18/2003US6534532 Carbanilides as pesticides
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/13/2003WO2003020677A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments
03/13/2003WO2002096901A3 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002074726A3 Aniline derivatives useful as phosphodiesterase 4 inhibitors
03/13/2003WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003US20030050324 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
03/13/2003US20030050317 (R)-chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/13/2003US20030050306 Novel heteroaryl derivatives, their preparation and use
03/13/2003US20030047720 For use as semiconductors or charge transport materials in optical, electrooptical or electronic devices including field effect transistors, electroluminescent, photovoltaic and sensor devices
03/12/2003WO2002022568A1 ss-THIO-AMINO ACIDS
03/12/2003EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/12/2003EP1291341A1 Compounds exhibiting thrombopoietin-like activities
03/12/2003EP1290059A1 Method of preparing a polymer, method of preparing a compound, compounds, polymers, and method of manufacturing an electronic device
03/12/2003EP1290000A1 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same
03/12/2003EP1289981A1 Novel electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides
03/12/2003EP1289980A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531599 Compounds having activity as inhibitors of cytochrome P450RAI
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531504 Prostanoic acid derivatives as agents for lowering intraocular pressure
03/11/2003US6531485 Prostaglandin agonists
03/11/2003US6531424 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
03/11/2003CA2242351C Novel tricyclic compounds and drug compositions containing the same
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/06/2003WO2003018710A1 Europium-ammonium tetra chelates
03/06/2003WO2003018572A1 3-(n-alkoxycarbonyl-n-methyl)amino-1-alkoxycarbonyl- oxy-(2-thienyl)propanes and process for preparing 3-(n- methylamino)-1-(2-thienyl)-propan-1-ol with the same
03/06/2003WO2003018571A1 M-aminophenol derivatives and colouring agents containing them
03/06/2003WO2003018536A1 Chemotherapeutic agents
03/06/2003WO2003018070A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
03/06/2003WO2003018029A1 Anti-bacterial agents based upon oxoanion binding
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2002098901A3 Peptide deformylase inhibitors
03/06/2003WO2002094770A3 Aminoalcohol derivatives
03/06/2003WO2002057224A3 Synthesis and antimicrobial activityof novel dicationic 'reversed amidines'
03/06/2003WO2002042261A3 PROCESS FOR PREPARING α-(3-ARYLTHIO)-ACETOPHENONES
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045726 Novel immunotherapeutic agents
03/06/2003US20030045581 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/06/2003US20030045579 Compounds and compositions for delivering active agents
03/06/2003US20030045569 Difluoromethylene aromatic ethers as inhibitors of glycine transport
03/06/2003US20030045518 Certain bis(thio-hydrazide amide) compounds significantly enhance the anticancer activity of taxol.
03/06/2003CA2458681A1 M-aminophenol derivatives and colouring agents containing them
03/06/2003CA2457676A1 Chemotherapeutic agents
03/06/2003CA2455504A1 Anti-bacterial agents based upon oxoanion binding
03/05/2003EP1288199A1 Mmp-12 inhibitors
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286955A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 329